ÂÜÀòÂÒÂ×

Deepika Dadhich is an accomplished Advance Business Analyst at Novo Nordisk since June 2024, bringing a wealth of experience from previous roles, including Senior Executive Quality Assurance at Anthem Biosciences Private Limited from January 2022 to June 2024. At Anthem Biosciences, Deepika was a core team member for SAP implementation and contributed to the Veeva Vault Validation Team. Prior to that, Deepika served as a Senior Executive at Biocon Biologics from August 2016 to December 2021, specializing in instruments qualification, computer system validation, and regulatory compliance. Deepika's early career includes a position as a Quality Control Executive, focusing on insulin drug product quality control. Deepika holds a Master's degree in Biotechnology from Garden City University and a Bachelor of Science in Biotechnology from Modi Institute of Management & Technology.